Total Payments
$1.8M
2024 Payments
$560,191
Companies
67
Transactions
1,673
Medicare Patients
11,492
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$924,556 (51.3%)
Consulting$658,161 (36.5%)
Travel$177,679 (9.9%)
Food & Beverage$42,818 (2.4%)
Education$465.31 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $874,833 | 322 | 48.5% |
| Consulting Fee | $658,161 | 90 | 36.5% |
| Travel and Lodging | $177,679 | 465 | 9.9% |
| Honoraria | $49,598 | 37 | 2.7% |
| Food and Beverage | $42,818 | 728 | 2.4% |
| Education | $465.31 | 12 | 0.0% |
| Grant | $125.00 | 1 | 0.0% |
| Unspecified | $0 | 18 | 0.0% |
Payments by Type
General
$1.8M
1,655 transactions
Ownership
$0
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $414,466 | 363 | $0 (2024) |
| Janssen Global Services, LLC | $341,148 | 112 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $196,296 | 248 | $0 (2024) |
| Merck Sharp & Dohme LLC | $121,432 | 80 | $0 (2023) |
| UroGPO LLC | $112,595 | 87 | $0 (2020) |
| Janssen Biotech, Inc. | $97,448 | 182 | $0 (2024) |
| Janssen Research & Development, LLC | $91,490 | 17 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $81,462 | 72 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $68,309 | 84 | $0 (2024) |
| SN Holdings, LLC | $52,641 | 77 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $560,191 | 237 | Janssen Global Services, LLC ($339,598) |
| 2023 | $168,214 | 167 | Merck Sharp & Dohme LLC ($28,935) |
| 2022 | $130,569 | 116 | Bayer HealthCare Pharmaceuticals Inc. ($37,183) |
| 2021 | $113,778 | 105 | Astellas Pharma US Inc ($20,341) |
| 2020 | $217,405 | 157 | Astellas Pharma US Inc ($62,439) |
| 2019 | $220,990 | 305 | Astellas Pharma US Inc ($73,071) |
| 2018 | $256,617 | 365 | Astellas Pharma US Inc ($84,310) |
| 2017 | $135,916 | 221 | Astellas Pharma US Inc ($67,289) |
All Payment Transactions
1,673 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $30,909.50 | General |
| 12/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,020.00 | General |
| Category: Oncology | ||||||
| 12/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $798.89 | General |
| Category: Oncology | ||||||
| 12/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $371.05 | General |
| Category: Oncology | ||||||
| 12/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $273.25 | General |
| Category: Oncology | ||||||
| 12/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $49.46 | General |
| Category: Oncology | ||||||
| 12/14/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $85.35 | General |
| Category: Oncology | ||||||
| 12/08/2024 | Janssen Global Services, LLC | — | Travel and Lodging | Cash or cash equivalent | $617.82 | General |
| 12/08/2024 | Janssen Global Services, LLC | — | Travel and Lodging | Cash or cash equivalent | $563.96 | General |
| 12/08/2024 | Janssen Global Services, LLC | — | Travel and Lodging | Cash or cash equivalent | $99.60 | General |
| 12/08/2024 | Janssen Global Services, LLC | — | Travel and Lodging | Cash or cash equivalent | $88.81 | General |
| 12/08/2024 | Janssen Global Services, LLC | — | Food and Beverage | Cash or cash equivalent | $65.00 | General |
| 12/08/2024 | Janssen Global Services, LLC | — | Travel and Lodging | Cash or cash equivalent | $48.00 | General |
| 12/08/2024 | Janssen Global Services, LLC | — | Travel and Lodging | Cash or cash equivalent | $12.06 | General |
| 12/08/2024 | Janssen Global Services, LLC | — | Food and Beverage | Cash or cash equivalent | $9.78 | General |
| 12/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $75.67 | General |
| Category: HORMONE THERAPY | ||||||
| 11/30/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $5,151.56 | General |
| 11/26/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $939.75 | General |
| 11/16/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $118.30 | General |
| Category: Oncology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $63.00 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $27,965.74 | General |
| 10/30/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,020.00 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $1,235.65 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $464.40 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 2,665 | 15,684 | $1.3M | $344,791 |
| 2022 | 34 | 2,646 | 17,146 | $1.2M | $328,843 |
| 2021 | 40 | 3,588 | 28,393 | $1.9M | $503,368 |
| 2020 | 34 | 2,593 | 19,239 | $1.2M | $330,820 |
Total Patients
11,492
Total Services
80,462
Medicare Billing
$1.5M
Procedure Codes
148
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 31 | 4,800 | $216,000 | $86,945 | 40.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 108 | 573 | $498,510 | $75,156 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 299 | 371 | $100,170 | $33,671 | 33.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 65 | 556 | $46,704 | $24,120 | 51.6% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 18 | 18 | $74,070 | $16,731 | 22.6% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 34 | 5,280 | $52,800 | $16,224 | 30.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 68 | 74 | $41,070 | $12,995 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 123 | 128 | $24,320 | $8,137 | 33.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 23 | 24 | $27,240 | $7,501 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 62 | $22,320 | $7,483 | 33.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 30 | 30 | $17,700 | $5,540 | 31.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 139 | 178 | $25,810 | $4,431 | 17.2% |
| 52351 | Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | Facility | 2023 | 19 | 23 | $19,090 | $4,366 | 22.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 173 | 235 | $16,450 | $4,217 | 25.6% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 22 | 1,500 | $10,500 | $3,402 | 32.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 30 | 30 | $12,630 | $3,272 | 25.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 355 | 385 | $12,320 | $3,194 | 25.9% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 29 | 39 | $11,505 | $2,677 | 23.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $7,263 | $2,654 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $9,430 | $2,448 | 26.0% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 41 | 41 | $9,225 | $2,357 | 25.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 27 | 27 | $12,456 | $2,221 | 17.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 33 | 41 | $7,790 | $1,902 | 24.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 37 | 42 | $3,234 | $1,634 | 50.5% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 48 | 61 | $4,575 | $1,522 | 33.3% |
About Dr. Michael Fabrizio, M.D
Dr. Michael Fabrizio, M.D is a Urology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427036664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Fabrizio, M.D has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $560,191 received in 2024. These payments were reported across 1,673 transactions from 67 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($874,833).
As a Medicare-enrolled provider, Fabrizio has provided services to 11,492 Medicare beneficiaries, totaling 80,462 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Washington, DC
- Active Since 01/06/2006
- Last Updated 12/27/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1427036664
Products in Payments
- XTANDI (Drug) $244,257
- Xtandi (Drug) $146,537
- Xofigo (Drug) $111,505
- Erleada (Drug) $97,913
- KEYTRUDA (Biological) $81,813
- Nubeqa (Drug) $75,357
- PROVENGE (Drug) $68,435
- ERLEADA (Drug) $61,318
- LYNPARZA (Drug) $45,925
- ORGOVYX (Drug) $44,922
- UROLIFT (Device) $17,094
- DARZALEX (Biological) $12,354
- NEPHROSCOPE MIP M (Device) $9,397
- Tulsa-Pro (Device) $8,111
- Non-Covered (Drug) $7,359
- TALZENNA (Drug) $6,535
- LYNPARZA (Biological) $6,033
- JEVTANA (Drug) $5,887
- JELMYTO (Drug) $5,164
- UROLIFT SYSTEM (Device) $2,750
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Washington
Dr. Patrick Mufarrij, Md, MD
Urology — Payments: $80,868
Urology $80,868
Dr. Jason Engel, M.d.,, M.D.,
Urology — Payments: $71,062
Urology $71,062
Dr. Nathan Shaw, M.d, M.D
Urology — Payments: $52,964
Urology $52,964
Dr. Armine Smith, Md, MD
Urology — Payments: $38,555
Urology $38,555
Dr. Damon Hoffmann, D.o, D.O
Urology — Payments: $31,247
Urology $31,247
Dr. Ryan Hankins, M.d, M.D
Urology — Payments: $23,654
Urology $23,654